Data gathered: May 17
Alternative Data for Esperion Therapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 8 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 16,000 | Sign up | Sign up | Sign up |
| Employee Rating | 69 | Sign up | Sign up | Sign up |
| Google Trends | 12 | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 125 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 8,299 | Sign up | Sign up | Sign up |
| Twitter Followers | 2,028 | Sign up | Sign up | Sign up |
| Twitter Mentions | 94 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 63 | Sign up | Sign up | Sign up |
| Linkedin Employees | 325 | Sign up | Sign up | Sign up |
About Esperion Therapeutics
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol.
| Price | $2.59 |
| Target Price | Sign up |
| Volume | 10,570,000 |
| Market Cap | $436M |
| Year Range | $0.73 - $3.24 |
| Dividend Yield | 0% |
| Revenue per Employee | $859,935 |
| Industry | Drug Manufacturers |
In the news
 |
Spire Wealth Management Acquires 7,267 Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR)May 14 - ETF Daily News |
 |
Esperion Therapeutics’ (ESPR) “Buy” Rating Reiterated at HC WainwrightMay 12 - ETF Daily News |
|
Esperion Therapeutics, Inc. Forecasted to Earn FY2026 Earnings of $2.19 Per Share (NASDAQ:ESPR)May 11 - ETF Daily News |
|
Q2 2024 EPS Estimates for Esperion Therapeutics, Inc. (NASDAQ:ESPR) Boosted by Northland CapmkMay 10 - ETF Daily News |
|
Zacks Research Research Analysts Cut Earnings Estimates for Esperion Therapeutics, Inc. (NASDAQ:ESPR)May 10 - ETF Daily News |
|
Investors Purchase Large Volume of Esperion Therapeutics Call Options (NASDAQ:ESPR)May 8 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '24 | 124M | 42M | 82M | 61M | 72M | 0.340 |
| Q4 '23 | 17M | 45M | -28M | -56M | -42M | -0.500 |
| Q3 '23 | 19M | 33M | -14M | -41M | -28M | -0.370 |
| Q2 '23 | 11M | 34M | -23M | -50M | -37M | -0.460 |
| Q1 '23 | 9.9M | 30M | -20M | -62M | -47M | -0.790 |
Insider Transactions View All
| Warren Eric filed to sell 68,318 shares at $1.2. September 21 '23 |
| Warren Eric filed to sell 69,060 shares at $1.4. August 21 '23 |
| Warren Eric filed to sell 69,303 shares at $1.6. July 20 '23 |
| Warren Eric filed to sell 69,409 shares at $1.5. June 22 '23 |
| Warren Eric filed to sell 70,012 shares at $1.6. May 18 '23 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$154.28 0% | 60 |
 |
Eli Lilly and CompanyLLY |
$771.12 0% | 71 |
 |
PfizerPFE |
$28.92 0% | 39 |
 |
AstrazenecaAZN |
$77.04 0% | 58 |
 |
AbbVieABBV |
$164.33 0% | 58 |
Read more about Esperion Therapeutics (ESPR) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Esperion Therapeutics?
The Market Cap of Esperion Therapeutics is $436M.
How Many People Work at Esperion Therapeutics?
As of our latest update, Esperion Therapeutics employed approximately 199 people worldwide. However, it's important to note that Esperion Therapeutics' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.
What is Esperion Therapeutics' revenue per employee?
$859,935. To calculate Esperion Therapeutics' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.
What is the current stock price of Esperion Therapeutics?
Currently, the price of one share of Esperion Therapeutics stock is $2.59.
How can I analyze the ESPR stock price chart for investment decisions?
The ESPR stock price chart above provides a comprehensive visual representation of Esperion Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Esperion Therapeutics shares. Our platform offers an up-to-date ESPR stock price chart, along with technical data analysis and alternative data insights.
Does ESPR offer dividends to its shareholders?
As of our latest update, Esperion Therapeutics (ESPR) does not offer dividends to its shareholders. Investors interested in Esperion Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Esperion Therapeutics?
Some of the similar stocks of Esperion Therapeutics are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.